Tumor heterogeneity and strategies to overcome kinase inhibitor resistance in cancer: Lessons from melanoma

Eitemau Tebyg

• Strategies for Overcoming Resistance to EGFR Family Tyrosine Kinase Inhibitors
  gan: Giaccone, Giuseppe, et al.
  Cyhoeddwyd: (2011)
• New Strategies in Overcoming Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer
  gan: Oxnard, Geoffrey R., et al.
  Cyhoeddwyd: (2011)
• The novel ATP-competitive MEK/Aurora kinase inhibitor BI-847325 overcomes acquired BRAF inhibitor resistance through suppression of Mcl-1 and MEK expression
  gan: Phadke, Manali S., et al.
  Cyhoeddwyd: (2015)
• Change or Die: Targeting Adaptive Signaling to Kinase Inhibition in Cancer Cells
  gan: Rebecca, Vito W., et al.
  Cyhoeddwyd: (2014)
• An immunometabolic prodrug strategy overcomes DHODH inhibitor resistance in refractory melanoma
  gan: Yongrui Hai, et al.
  Cyhoeddwyd: (2025-11-01)